학술논문

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials
Document Type
Article
Source
In: Vaccine. (Vaccine, 2 November 2022, 40(46):6599-6606)
Subject
Language
English
ISSN
18732518
0264410X